Guardant Health's total inventories for the quarter that ended in Mar. 2022 was $36.6 Mil. Guardant Health's average total inventories from the quarter that ended in Dec. 2021 to the quarter that ended in Mar. 2022 was $33.6 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Guardant Health's Net-Net Working Capital per share for the quarter that ended in Mar. 2022 was $-5.42.
Inventory can be measured by days sales of inventory (DSI).
Guardant Health's days sales of inventory (DSI) for the
three
months ended in Mar. 2022 was 31.95.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Guardant Health's Days Inventory for the
three
months ended in Mar. 2022 was 95.99.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Guardant Health's Inventory Turnover for the quarter that ended in Mar. 2022 was 0.95.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Guardant Health's Inventory-to-Revenue for the quarter that ended in Mar. 2022 was 0.35.
Guardant Health Total Inventories Historical Data
The historical data trend for Guardant Health's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Guardant Health Annual Data
Trend
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Total Inventories
7.29
9.14
15.18
22.72
30.67
Guardant Health Quarterly Data
Dec16
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Total Inventories
28.88
26.49
24.74
30.67
36.61
Guardant Health Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Guardant Health (NAS:GH) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Guardant Health's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2022 is
5. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Guardant Health's Inventory to Revenue for the quarter that ended in Mar. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Guardant Health Total Inventories Related Terms
Thank you for viewing the detailed overview of Guardant Health's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.
Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. The company offers Guardant 360, a blood-based (liquid biopsy) test for treatment selection in advanced stage cancer, and Guardant Omni, a broader gene panel for immuno-oncology research. The company's pipeline includes Guardant Reveal (formerly Lunar-1), for cancer recurrence detection in survivors, and Lunar-2, a liquid biopsy for early detection of cancer in higher-risk individuals, with an initial focus on colorectal cancer. Additionally, Guardant offers research development services. The United States accounts for 90% of total revenue, and other markets the remaining 10%.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
4.48(11.63%) Volume: 1,303,995 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:GH has been successfully added to your 
